1. Long Noncoding RNA FGFR3-AS1 Promotes Hepatocellular Carcinoma Carcinogenesis via Modulating the PI3K/AKT Pathway
   Juhua Zhuang et al, 2018, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
2. MicroRNAs and Long Non-Coding RNAs as Regulators of NANOG Expression in the Development of Oral Squamous Cell Carcinoma
   Gašper Grubelnik et al, 2021, Frontiers in Oncology CrossRef
3. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway
   Xu Wang et al, 2019, Journal of Cellular Biochemistry CrossRef
4. Noncoding RNAs Associated with Therapeutic Resistance in Pancreatic Cancer
   Seung Wan Son et al, 2021, Biomedicines CrossRef
5. Long noncoding RNA MINCR regulates cellular proliferation, migration, and invasion in hepatocellular carcinoma
   Jinyu Cao et al, 2018, Biomedicine & Pharmacotherapy CrossRef
6. Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630/miR-373/EphB2-NANOG signals
   Peng Chen et al, 2019, Bioscience Reports CrossRef
7. Identification of Ten Long Noncoding RNAs as Biomarkers for Hepatocellular Carcinoma
   Chao Lin et al, 2020, Brazilian Archives of Biology and Technology CrossRef
8. LncRNA OIP5-AS1 interacts with miR-363-3p to contribute to hepatocellular carcinoma progression through up-regulation of SOX4
   Jianchu Wang et al, 2020, Gene Therapy CrossRef
9. LncRNA AB209630 inhibits gemcitabine resistance cell proliferation by regulating PI3K/AKT signaling in pancreatic ductal adenocarcinoma
   Libin Wang et al, 2018, Cancer Biomarkers CrossRef